Brooke received her BA from the University of California, Santa Cruz and her PhD from Northwestern University. As a PhD student in the laboratory of Navdeep Chandel, Brooke identified and characterized novel signaling pathways that regulate the transcription factor hypoxia inducible factor-1. Upon completion of her PhD, Brooke joined the laboratory of Lewis Cantley at Harvard Medical School. There she discovered that the loss of function of the PI5P4Ks resulted in synthetic lethality with p53 loss and began to elucidate the role of the PI5P4K family of enzymes in cancer metabolism. After she completed her postdoctoral fellowship at Harvard Medical School, Brooke became an Instructor of Cancer Biology in Medicine at Weill Cornell Medicine where she continued her research on lipid kinase signaling and cancer metabolism. In August 2016, Brooke joined the faculty at Sanford Burnham Prebys as an Assistant Professor.

Ryan received his BS in Biology from the University of Pittsburgh. Before joining the Emerling lab in 2016, Ryan was a research technician in the Cantley Lab at Weill Cornell Medicine. As a graduate student in the Emerling lab, he is currently focusing on uncovering the mechanism by which the PI5P4K enzymes act as compensatory metabolic sensors in p53 mutant cancers. In his spare time, he enjoys golf, tennis, and attempting to write the next Hugo award winning sci-fi novel.

Gurpreet received her PhD in Cell and Molecular Biology from The University of Rochester. Before joining the Emerling lab, she was a postdoc at UT Southwestern Medical Center where she worked on identifying and characterizing factors that drive cancer cachexia, with the focus being on adipose wasting. Currently her research aims at understanding the biology of PI5P4K enzymes in cancer metabolism. Gurpreet enjoys photography, traveling and playing sports during her spare time.